While a number of prior studies have reported greater rates of cognitive decline among cognitively normal APOE-ε4 carriers (for a review, see [60]), studies examining the relationship of AD-PRS with cognitive decline have been more limited. The gene discussed is APOE; the disease is Alzheimer disease.